NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)MALECARE INC, founded in 1999, is a small nonprofit in the Diseases & Disorders sector that reported $327K in total revenue in fiscal year 2025. Revenue surged 716% from the prior year, signaling strong growth momentum. Expenses of $286K left a modest 13% surplus.
MALECARE'S MISSION IS TO HELP PEOPLE LIVE LONGER AND HAPPIER LIVES.MALECARE IMPROVES THE LIVES OF PEOPLE DIAGNOSED WITH CANCER, THEIR FAMILIES AND COMMUNITIES BY MAKING HEALTH SERVICES SAFE, AVAILABLE, UNDERSTANDABLE AND SUSTAINABLE. WE PROVIDE TECHNICAL ASSISTANCE, TRAINING, AND INFORMATION, WITH A FOCUS ON PRACTICAL SOLUTIONS THAT IMPROVE SERVICES WHERE RESOURCES ARE SCARCE. WE BELIEVE THAT INDIVIDUALS HAVE THE RIGHT TO MAKE INFORMED DECISIONS ABOUT THEIR HEALTH AND TO RECEIVE CARE THAT MEETS THEIR NEEDS. WE FOCUS ON HELPING UNDER-SERVED COMMUNITIES SUCH AS AFRICAN AMERICAN MEN, LGBT PEOPLE AND LATINO MEN.MALECARE IS COMMITTED TO DESIGNING AND IMPLEMENTING CONTEXTUAL, CULTURALLY COMPETENT AND PROACTIVE MEN'S HEALTH CARE SERVICES, WHERE EVER THERE IS NEED. BARRIERS ARE TO BE BROKEN AND EVERYONE DESERVES ACTION. OUR WORK FOR PROSTATE, TESTICULAR AND MALE BREAST CANCER PATIENTS IS PRESENTED IN ENGLISH, SPANISH, HEBREW, FRENCH AND ITALIAN.
MALECARE IS A NATIONAL CANCER PATIENT SUPPORT AND ADVOCACY NONPROFIT ORGANIZATION. WE ARE A DYNAMIC, NIMBLE, AND CUTTING EDGE COMPANY STRIVING TO BE FIRST IN UNDERSTANDING AND IMPLEMENTING NEW...
MALECARE IS A NATIONAL CANCER PATIENT SUPPORT AND ADVOCACY NONPROFIT ORGANIZATION. WE ARE A DYNAMIC, NIMBLE, AND CUTTING EDGE COMPANY STRIVING TO BE FIRST IN UNDERSTANDING AND IMPLEMENTING NEW TECHNOLOGY IN SERVICE TO OUR CANCER SURVIVOR POPULATION. MALECARE PROVIDES HEALTH PROGRAMS FOR UNDERSERVED POPULATIONS, LIKE BLACK AND AFRICAN-AMERICAN, AND LGBT CANCER SURVIVORS. WE PROVIDE OUR SERVICES WITHOUT COST TO PATIENTS AND THEIR FAMILIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $327,358 | $40,135 | +7.2% |
| Expenses | $286,033 | $279,532 | +0.0% |
| Net Income | $41,325 | $-239,397 | -1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BRUCE SHENITZ | CHAIR/TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| VINCENT SANTILLO MD | VICE CHAIR | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| DARRYL MITTELDORF | EXECUTIVE DIRECTOR | 55.00 |
Officer
Director
|
$189,200 | $36,448 | $225,648 |
| KEITH SHEPARD | SECRETARY | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $327,358 | $286,033 | $1,440,543 | $41,325 |
| 2024 | No data | No data | No data | No data |
| 2023 | $571,570 | $269,575 | $1,639,020 | $301,995 |
| 2022 | $1,021,936 | $194,221 | $1,337,066 | $827,715 |
| 2021 | $461,759 | $205,933 | $514,341 | $255,826 |
| 2020 | $332,548 | $187,186 | $255,076 | $145,362 |
| 2019 | $205,067 | $217,132 | $109,442 | $-12,065 |
| 2018 | $208,764 | $147,223 | $134,131 | $61,541 |
Compare MALECARE INC with other nonprofits in New York and across the country.